AptarGroup, Inc. (ATR)

Market Cap	9.30B
Revenue (ttm)	3.54B
Net Income (ttm)	312.83M
Shares Out	66.26M
EPS (ttm)	4.66
PE Ratio	30.13
Forward PE	25.39
Dividend	$1.64 (1.17%)
Ex-Dividend Date	Apr 24, 2024

Volume	250,460
Open	138.48
Previous Close	138.54
Day's Range	137.75 - 140.50
52-Week Range	111.63 - 151.73
Beta	0.60
Analysts	Buy
Price Target	166.50 (+18.59%)
Earnings Date	Jul 25, 2024

About ATR

AptarGroup, Inc. designs and manufactures a range of drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, beauty, personal care, home care, and food and beverage markets. The company operates through Aptar Pharma, Aptar Beauty, and Aptar Closures segments. It also provides pumps for nasal allergy treatments; and metered dose inhaler valves for respiratory ailments, such as asthma and chronic obstructive pulmonary diseases; elastomer for injectable primary packaging components; an...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Apr 21, 1993
• Employees: 13,800
• Stock Exchange: NYSE
• Ticker Symbol: ATR

Financial Performance

In 2023, AptarGroup's revenue was $3.49 billion, an increase of 4.97% compared to the previous year's $3.32 billion. Earnings were $284.49 million, an increase of 18.89%.

Analyst Forecast

According to 3 analysts, the average rating for ATR stock is "Buy." The 12-month stock price forecast is $166.5, which is an increase of 18.59% from the latest price.

Price Target

$166.5

(18.59% upside)

Analyst Consensus: Buy